Cell C CEO Mendes JSE Share Purchase: R20.8M Acquisition Meets JSE Rules

• Cell C CEO Jorge Mendes acquired 792,187 shares in the company through two on-market transactions.
• The total value of these share purchases amounted to R20.81 million.
• The acquisitions, made on September 17 and September 21, were in Mendes’ direct beneficial interest.
• Required clearance was obtained, and disclosures complied with JSE Listings Requirements paragraphs 6.77 to 6.89.
• Mendes has led a broad turnaround strategy for Cell C since becoming CEO in June 2023, including debt reduction and a brand refresh.

When a chief executive makes a direct, multi-million rand investment in their own company, it often signals strong confidence in its future prospects and strategic direction.

Cell C CEO Jorge Mendes recently made a substantial personal investment in the telecommunications company, acquiring shares valued at nearly R20.8 million through two distinct on-market transactions. This significant Cell C CEO Mendes JSE share purchase underscores a direct financial stake by the executive in the firm's future.

The first acquisition occurred on September 17, when Mendes purchased 52,187 ordinary shares at a price of R23 each, totaling R1.2 million. Just four days later, on September 21, a second, larger transaction took place, involving the acquisition of 740,000 shares at R26.50 per share, amounting to R19.61 million. These two transactions combined resulted in Jorge Mendes's Cell C share acquisition of 792,187 shares, with a cumulative value of R20.81 million. Both purchases were executed on the open market and were recorded as being in Mendes’ direct beneficial interest.

Crucially, the necessary internal clearance for these transactions was secured prior to their execution. Furthermore, the subsequent disclosures were made in full compliance with the JSE Listings Requirements, specifically referencing paragraphs 6.77 to 6.89, which govern director dealings and executive shareholding disclosure for listed entities in South Africa.

The recent share acquisitions by Cell C CEO Jorge Mendes serve as a practical illustration of the stringent compliance obligations faced by directors of companies listed on the Johannesburg Stock Exchange (JSE). These transactions were explicitly reported as adhering to paragraphs 6.77 to 6.89 of the JSE Listings Requirements, which mandate transparency and proper procedure for director dealings.

These specific paragraphs outline the rules for disclosing dealings in securities by directors, their associates, and prescribed officers, ensuring that the market is promptly informed of such significant transactions. For South Africa listed company share transactions involving executives, obtaining prior clearance is a fundamental step, as was confirmed in this instance. This process is designed to prevent insider trading and maintain market integrity, reinforcing the importance of robust internal clearance processes for executive share transactions.

The meticulous disclosure of Mendes's share purchases highlights the ongoing commitment required from listed entities and their leadership to uphold regulatory standards. Such executive shareholding disclosure is vital for investor confidence, providing clarity on the financial interests of key management personnel in the company's performance.

Jorge Mendes assumed the role of Cell C CEO in June 2023, embarking on a comprehensive turnaround strategy for the financially challenged operator. His tenure has been marked by significant strategic initiatives aimed at restoring the company to sustainable growth and profitability.

Key aspects of this transformation include a substantial overhaul of the executive committee, bringing in experienced telecoms professionals, some of whom previously worked with Mendes at Vodacom. The company also undertook a comprehensive brand refresh, introducing a new identity, updated products, modern retail stores, and rebuilt digital channels to enhance customer engagement and market presence. Financially, the turnaround involved a significant reduction in debt, from R9 billion to R3 billion, alongside a restructuring of network and roaming arrangements to improve operational efficiency.

Cell C's listing on the JSE in November 2025 marked a pivotal moment, and its initial financial results as a publicly traded entity indicated continued progress in strengthening its balance sheet and stabilizing the overall business operations. Mendes's personal investment in the company's shares occurs within this context of ongoing strategic efforts and a renewed focus on corporate stability and growth.

The substantial investment by Cell C CEO Mendes in the company's shares carries significant implications for market perception and executive alignment. When a chief executive makes a direct, multi-million rand investment in their own company, it often signals strong confidence in its future prospects and strategic direction. This move can reassure investors and stakeholders about the leadership's commitment to the company's long-term success.

Such a significant Jorge Mendes Cell C share acquisition demonstrates a clear alignment of personal financial interests with those of the shareholders. It reinforces the message that the executive believes in the value creation potential of the ongoing turnaround efforts and the strategic decisions being implemented.

For the broader market, transparent director dealings, especially those complying with JSE Paragraphs 6.77 to 6.89, are crucial for maintaining trust and a level playing field. This particular Cell C executive shareholding disclosure provides a tangible example of a leader backing their strategic vision with personal capital, contributing to the narrative of a company actively working towards stability and growth following its recent JSE listing.

This article serves as a practical example of director dealings in a listed company, highlighting the ongoing compliance obligations under JSE Listings Requirements, specifically paragraphs 6.77 to 6.89. Lawyers and compliance officers should note the importance of proper disclosure and internal clearance processes for executive share transactions to ensure regulatory adherence.

Source: Original reporting via market reports.